CFD
LGND icon

Creative Financial Designs’s Ligand Pharmaceuticals LGND Stock Holding History

Creative Financial Designs’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.16K Hold
10
– – ﹤0.01% 1820
2026
Q1 		$2K Hold
10
– – ﹤0.01% 1781
2025
Q4 		$1.89K Hold
10
– – ﹤0.01% 1692
2025
Q3 		$1.77K Hold
10
– – ﹤0.01% 1716
2025
Q2 		$1.14K Hold
10
– – ﹤0.01% 1763
2025
Q1 		$1.05K Sell
10
-10
-50% -$1.13K ﹤0.01% 1769
2024
Q4 		$2.14K Buy
+20
New +$2.26K ﹤0.01% 1581

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Creative Financial Designs's LGND Position: Q2 2026 in Review

Creative Financial Designs held its Ligand Pharmaceuticals (LGND) position steady in Q2 2026 at 10 shares worth $3.16K. The position accounts for ﹤0.01% of the portfolio, ranked #1820.

Creative Financial Designs first reported a position in LGND in Q4 2024 and has held it in 7 quarters since. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Creative Financial Designs held 10 shares of Ligand Pharmaceuticals worth $3.16K as of Q2 2026.
  • Creative Financial Designs left its Ligand Pharmaceuticals share count unchanged in Q2 2026.
  • Ligand Pharmaceuticals made up ﹤0.01% of Creative Financial Designs's portfolio in Q2 2026, its #1820 holding.
  • Creative Financial Designs first reported a position in Ligand Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Creative Financial Designs's 13F filing for Q2 2026, filed 28 Jul 2026.